Omicron

Bio & Pharma Cellid applies for Phase 3 clinical trials in S.Korea for COVID-19 vaccine

South Korean bio-venture Cellid Co. announced on Tuesday that it has applied for the clinical Phase 3 trial of the COVID-19 Omicron variant-specific...

Entertainment BTS returns to Korean stage for 1st time since 2019

SEOUL — In the latest sign that life is going back to something that resembles the pre-pandemic past, BTS is returning to the stage in Seoul.The...

Korean stock market Korea’s reopening stocks shine despite surging Omicron cases

South Korea’s reopening stocks rallied even as the local COVID-19 cases hit record-highs with the spread of the Omicron variant. Investors rai...

Pharamaceuticals, biotech Celltrion to conduct tests on Omicron variant detected in Korea

Biopharmaceutical powerhouse Celltrion Inc. plans to use its treatments to test the Omicron variant detected in Korea, according to a high-level com...

COVID-19 Korea’s reopening stocks jump on easing Omicron woes

South Korea’s reopening stocks surged on Dec. 3 as US President Joe Biden’s plans to curb the Omicron variant of COVID-19 exclude lockdo...